SCHEMBL12377619

SCHEMBL12377619

Cc1cc(C(=O)OCc2ccccc2)cc(C)c1OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.60
KMT2A Q03164 3/20 0.60
SLC6A2 P23975 1/20 0.60
SLC6A3 Q01959 1/20 0.60
LMNA P02545 4/20 0.58
HPGD P15428 2/20 0.58
ALDH1A1 P00352 4/20 0.52
MAPT P10636 3/20 0.52
RAB9A P51151 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
NPC1 O15118 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GLRA1 P23415 1/20 0.48
PTPN1 P18031 1/20 0.48
GAA P10253 1/20 0.48
JMJD6 Q6NYC1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL262646 0.86 MEN1 (0.63) KMT2ALMNAHPGDGLRA1PTPN1
Hydrochloric Acid SCHEMBL16143479 0.84 MEN1 (0.61) KMT2ALMNAHPGDGLRA1PTPN1
SCHEMBL4784102 0.84 MAOB (0.59) TDP1KMT2ALMNAHPGDALDH1A1
SCHEMBL3042119 0.84 TDP1 (0.64) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL794412 0.83 KMT2A (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL22015355 0.83 LMNA (0.78) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL4311512 0.83 TDP1 (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL20401024 0.83 TDP1 (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL348412 0.83 GLRA1 (0.68) KMT2ALMNAHPGDALDH1A1GLRA1
SCHEMBL23226754 0.82 FFAR4 (0.59) TDP1KMT2ASLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003699-B2 Amide compound and use thereof for controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-23 US disclosed
US-7902400-B2 N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-08 US disclosed
US-20100137445-A1 PLANT DISEASE CONTROL AGENT, AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY ,LIMITED 2010-06-03 US disclosed
US-7714168-B2 N-(1,1-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; N-(2,2-diemthylpropyl)-4-(2-propynyloxy)-3-methoxybenzamide; controlling plant diseases SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
US-20100105647-A1 AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING PLANT DISEASES SUMITOMO CHEMICAL COMPANY, LIMITED 2010-04-29 US disclosed
US-20100069499-A1 AMIDE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-18 US disclosed
US-20090131531-A1 Amide Compounds and their Use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-21 US disclosed
US-20080319080-A1 Amide Compounds and Their Use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131531-A1 Amide Compounds and their Use NAT1, ACAT2, NAAA TDP1 3052/4885KMT2A 909/4885SLC6A2 3522/4885
US-20100069499-A1 AMIDE COMPOUND AND USE THEREOF CBR1, CBR3, GBA1 TDP1 4368/4885KMT2A 1752/4885SLC6A2 4493/4885
US-20100105647-A1 AMIDE COMPOUND AND USE THEREOF FOR CONTROLLING PLANT DISEASES CYC1, CBR3, CBR1 TDP1 4393/4885KMT2A 1706/4885SLC6A2 4634/4885
US-20100137445-A1 PLANT DISEASE CONTROL AGENT, AND PLANT DISEASE CONTROL METHOD CBR3, CBR1, HDHD5 TDP1 4583/4885KMT2A 1467/4885SLC6A2 4709/4885
US-20080319080-A1 Amide Compounds and Their Use NAT1, ACAT2, NAAA TDP1 2896/4885KMT2A 896/4885SLC6A2 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.